(Q36040633)

11 August 2017

The Efficacy of Propranolol in Retinopathy of Prematurity and its Correlation with the Platelet Mass Index (English)

1 reference

retinopathy of prematurity

11 August 2017

1 reference

Levent Korkmaz

1

1 reference

11 August 2017

Osman Baştuğ

2

1 reference

11 August 2017

Ahmet Ozdemir

3

1 reference

11 August 2017

Sabriye Korkut

4

1 reference

11 August 2017

Cagatay Karaca

5

1 reference

11 August 2017

Mustafa Ali Akin

6

1 reference

11 August 2017

Tamer Gunes

7

1 reference

11 August 2017

Selim Kurtoglu

8

1 reference

11 August 2017

Mehmet Adnan Ozturk

9

1 reference

11 August 2017

3 June 2016

1 reference

11 August 2017

1 reference

11 August 2017

42

1 reference

11 August 2017

1

1 reference

11 August 2017

88-97

1 reference

Variations in practice and outcomes in the Canadian NICU network: 1996-1997.

11 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Pathological basis of retrolental fibroplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Pathogenesis of retinopathy of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Through the eyes of a child: understanding retinopathy through ROP the Friedenwald lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Propranolol induces regression of hemangioma cells through HIF-1α-mediated inhibition of VEGF-A.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Investigating the Association between Angiogenic Cytokines and Corneal Neovascularization in Sulfur Mustard Intoxicated Subjects 26 Years after Exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Grating visual acuity results in the early treatment for retinopathy of prematurity study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

On safety, pharmacokinetics and dosage of bevacizumab in ROP treatment - a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Intravitreal bevacizumab for retinopathy of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Propranolol for severe hemangiomas of infancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Perinatal infection, inflammation, and retinopathy of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Mechanisms and management of retinopathy of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

The neurovascular retina in retinopathy of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Long term functional and structural outcomes of laser therapy for retinopathy of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Antiangiogenic effects of β2 -adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Retinopathy of prematurity and pulse oximetry: a national survey of recent practices

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Risk factors of retinopathy of prematurity in premature infants weighing less than 1600 g.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Survey on retinopathy of prematurity (ROP) in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

High or low oxygen saturation and severe retinopathy of prematurity: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Fungal and bacterial sepsis and threshold ROP in preterm very low birth weight neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Association of postnatal dexamethasone use and fungal sepsis in the development of severe retinopathy of prematurity and progression to laser therapy in extremely low-birth-weight infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Effects of maternal and placental inflammation on retinopathy of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Maternal preeclampsia is associated with an increased risk of retinopathy of prematurity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Neonatal outcome of temporizing treatment in early-onset preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Preeclampsia and retinopathy of prematurity in preterm births

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Decreased incidence of retinopathy of prematurity, 1995-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Antenatal dexamethasone and decreased severity of retinopathy of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

Postnatal dexamethasone treatment and retinopathy of prematurity in very-low-birth-weight neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2016.1158272

10.3109/02713683.2016.1158272

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference